Header Image

Acute Kidney Injury Following Surgery

Post-operative Acute Kidney Injury in surgical patients is a well documented risk. It can prolong hospital stay, mean poorer quality of life and even shorten life expectancy. It is also very costly to treat.

Its incidence is one of the main measures of poor surgical outcome. Indeed the studies say that even in routine surgery about 8% of patients are likely to suffer. That means almost one person in ten comes out of surgery with a potentially serious condition. 

A condition that they didn’t suffer from when they went into hospital 

It may seem surprising that the healthcare industry often considers post-op complications like Acute Kidney Injury to be an acceptable risk. Moreso because prevention measures are so readily available.

An explanation may lie in the reality of the real world hospital setting. Certainly there can be a disconnect between the operation and the outcome beyond the surgery. This means that because Acute Kidney Injury sometimes become evident much later, the statistics may not always attribute it to peri-operative practices. 

Many studies, including FEDORA look at the incidence of avoidable conditions that we can relate to peri-operative care. Deltex’s mission is to help clinicians recognise and avoid adverse outcomes such as Acute Kidney Injury and Surgical Site Infection. 

The mission starts with drawing attention to the problem. Usefully it extends to providing a solution. 

Acute Kidney Injury Avoidance Strategy

Ultimately the answer lies in adopting haemodynamic protocols during surgery. The anaesthetist can achieve massive reductions in incidence of Acute Kidney Injury, SSI and other complications. It’s vital to maintain levels of perfusion of organs including the kidneys. Keeping the patient in a state of fluid balance means managing blood flow and blood pressure. Twenty years of experience and 22 RCTs provide the evidence that this works.

Oesophageal Doppler Monitoring (ODM) delivered by the Deltex TrueVue platform is the solution. It is the only haemodynamic management tool to deliver real time, accurate blood flow and pressure information directly from the patient’s aorta. Furthermore ODM is also the only technology to be backed by a body of independent clinical studies. 

Adverse surgical outcomes need not occur at the published levels. Deltex is here to help you deliver the best outcomes. We’re here to help you to avoid the avoidable.

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:


Registered in England & Wales Company No: 1691369